U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836557) titled 'Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis' on April 01, 2024.
Brief Summary: This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.
Study Start Date: Jan. 09, 2024
Study Type: INTERVENTIONAL
Condition:
Idiopathic Gastroparesis
Diabetic Gastroparesis
Gastroparesis
Intervention:
DRUG: Tradipitant
BID
Recruitment Status: RECRUITING
Sponsor: Vanda Pharmaceuticals
Disclaimer: Curated by HT Syndication....